Diclofenac for Bruising (Contusion)
Topical diclofenac is effective and FDA-approved for treating acute soft tissue injuries including contusions (bruises), providing significant pain relief with minimal systemic side effects. 1
FDA-Approved Indication
Topical diclofenac formulations are specifically indicated for treating pain from acute soft tissue injuries, which explicitly includes contusions 1, 2, 3. The FDA label for diclofenac topical solution states it is approved for "treatment of the pain of osteoarthritis," but the diclofenac patch formulation (FLECTOR) is approved for "acute pain due to minor strains, sprains, and contusions" 2.
Evidence for Efficacy in Contusions
Multiple high-quality randomized controlled trials demonstrate that topical diclofenac significantly reduces pain from contusions:
A 2016 double-blind RCT (n=164) showed diclofenac patch reduced pain on movement by 24.25 mm more than placebo at 48 hours (p<0.001) in patients with acute soft tissue injuries including contusions 4
A 2020 systematic review of 11,000+ participants confirmed topical diclofenac is effective for acute pain conditions like sprains and contusions, with a number needed to treat (NNT) of 1.8 for diclofenac Emulgel and 4.7 for diclofenac plaster 5
A 2011 RCT (n=418) demonstrated statistically significant pain reduction beginning after the second patch application, with median time to pain resolution shortened by 2 days compared to placebo (p=0.007) 3
A 2012 trial showed progressive pain decline in contusion patients, with diclofenac-heparin plaster superior to diclofenac alone and both superior to placebo 6
Formulation Selection
For acute contusions, the diclofenac patch or gel formulations are preferred:
Diclofenac patch (140-180 mg) applied twice daily for 7-14 days provides effective pain relief with once or twice daily application 4, 7
Diclofenac gel (topical) applied 3 times daily is an alternative option 8
The patch formulation offers convenience with less frequent application and comparable efficacy to gel formulations 4, 7
Safety Profile
Topical diclofenac has an excellent safety profile with minimal systemic absorption:
Local adverse events occur in only 4-8% of patients, primarily mild application site reactions (pruritus, erythema, mild skin irritation) 2, 3, 5
Systemic NSAID exposure is minimal with topical formulations, reducing risk of gastrointestinal bleeding, cardiovascular events, and renal toxicity compared to oral NSAIDs 9, 10
In pediatric populations (ages 6-16), topical diclofenac showed maximum tolerability scores of only 1 (faint redness) with minimal systemic drug exposure 2
Clinical Application Algorithm
For treating a contusion (bruise):
Apply diclofenac patch (140-180 mg) twice daily OR diclofenac gel 3 times daily to the affected area within 96 hours of injury 2, 4, 3
Continue treatment for 7-14 days or until pain resolution, whichever comes first 4, 3
Do not apply to open wounds, infections, or broken skin 1
Expected response: pain reduction within hours of first application, with significant relief by day 2-3 4, 3
Important Contraindications and Precautions
Avoid topical diclofenac in patients with:
- Known hypersensitivity to diclofenac or aspirin-sensitive asthma 1
- Pregnancy at ≥30 weeks gestation (risk of premature ductus arteriosus closure) 1
- Concurrent anticoagulation therapy (oral NSAIDs should be avoided; topical NSAIDs may be considered with caution) 9, 11
- Advanced renal disease unless benefits outweigh risks 1
Use with caution in:
- Patients >60 years with cardiovascular disease, hypertension, or heart failure 9, 1
- Patients with history of gastrointestinal bleeding (though topical formulations have lower risk than oral NSAIDs) 9, 10
Comparison to Oral NSAIDs
Topical diclofenac provides comparable pain relief to oral NSAIDs for localized injuries but with significantly fewer systemic adverse events 5. For elderly patients or those with multiple comorbidities, topical formulations are preferred over oral NSAIDs due to better safety profiles 10. A 2024 trauma guideline noted that while NSAIDs need caution in elderly patients due to renal and gastrointestinal risks, topical analgesics like diclofenac have better safety profiles 12.